These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7417352)

  • 1. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
    Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
    Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H; Leirisalo M; Tiilikainen A; Laitinen O
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia arthritis, immune functions and histocompatibility antigens.
    Repo H; Leirisalo-Repo M; Gripenberg M; Koskimies S; Kontiainen S; Laitinen O
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro.
    Repo H; Leirisalo-Repo M; Koskimies S
    Clin Exp Rheumatol; 1988; 6(3):227-31. PubMed ID: 3263238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in Yersinia arthritis.
    Repo H; Meri S; Leirisalo-Repo M
    Contrib Microbiol Immunol; 1987; 9():141-4. PubMed ID: 3499289
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors.
    Repo H; Leirisalo M; Kosunen TU
    J Immunol Methods; 1981; 46(2):227-42. PubMed ID: 7310132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
    Koivuranta-Vaara P; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
    Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
    Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M; Laitinen O; Tiilikainen A
    J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous Yersinia arthritis.
    Ristola M
    APMIS; 1990 Feb; 98(2):125-30. PubMed ID: 2302347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation and HLA-B27.
    Meri S; Partanen J; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O; Leirisalo M; Skylv G
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil function and HLA-B27.
    Repo H; Leirisalo M; Koivuranta P; Osterman T; Kiistala U; Gahmberg CG; Vapaatalo H; Tiilikainen A; Laitinen O
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.
    Repo H; Leirisalo-Repo M; Skurnik M; Tiilikainen A
    Med Biol; 1984; 62(2):91-4. PubMed ID: 6088912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B27, ankylosing spondylitis and polymorph motility.
    Pease CT; Currey HL
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):172-6. PubMed ID: 6606471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.
    Pease CT; Fordham JN; Currey HL
    Ann Rheum Dis; 1984 Apr; 43(2):279-84. PubMed ID: 6608924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
    Repo H; Leirisalo-Repo M
    Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.